Medijuana is a modern hybrid-indica whose exact origins are undocumented. Because breeders have not publicly confirmed the cross, its genetic lineage remains entirely unconfirmed and incomplete. This strain is cultivated for its moderate difficulty, requiring sixty days to complete its flowering phase, and it rewards growers in both indoor and outdoor environments with high yields.

The terpene profile of Medijuana is confirmed to feature caryophyllene as its dominant compound, followed by terpinolene, myrcene, linalool, limonene, humulene, bisabolol, beta-pinene, and pinene. Users can expect an estimated cannabinoid content of 17.8% THC, balanced by an estimated 0.04% CBD. Given this chemical makeup, the sensory experience tends to reflect the influence of its heavy caryophyllene and terpinolene base.

In practice, this strain provides users with effects that are distinctly relaxed and focused. It is commonly utilized by patients seeking relief from pain, stress, and sleep difficulties. Despite its presence in the modern market, there are no recorded offspring attributed to Medijuana at this time.